Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetcall Regulatory News (NET)

Share Price Information for Netcall (NET)

Share Price is delayed by 15 minutes
Get Live Data
125.50    0.00 (0.00%)
Bid:
123.00
Ask:
128.00
Spread: 5.00 (4.065%)
Market Cap: £214.10m
NET Live PriceLast checked at - London Stock Exchange

Intraday Netcall Share Chart

One in five NHS Trusts use AMC

10 Apr 2013 07:00

RNS Number : 9639B
Netcall PLC
10 April 2013
 



 

10 April 2013

NETCALL PLC

("Netcall", the "Company" or the "Group")

 

Netcall's Appointment Management Cycle now helping one in five NHS Acute Trusts and Health Boards save millions

 

Netcall plc (AIM: NET), a leading customer engagement software provider, is pleased to announce that following two recent contract wins, one in five of the NHS Acute Trusts and Health Boards in the UK are now implementing applications from Netcall's award winning Appointment Management Cycle (AMC) designed to combat "Did not attend" (DNA) rates and manage appointment systems in the healthcare market.

 

AMC was the first combined application suite to be launched following Netcall's acquisition of Telephonetics in July 2010 and this has recently been augmented with additional business process automation modules from Netcall's Eden solution set.

 

The pressure on the NHS continues to grow as it seeks ways to deliver £20bn of efficiency savings over four years to bridge the gap between flat funding and rising demand. This is against a backdrop of rising patient expectations and call for better services. Patient communication is expected to be one of the top three areas of future NHS IT spend according to a recent report from EH Insider.

 

High DNA rates, caused by the public not attending their appointments, are a major drain on healthcare resources and are believed to cost the NHS in the region of £700m a year. Netcall's Appointment Management Cycle suite has been designed specifically to empower Trusts to 'Remind, Rebook and Refill' appointments efficiently. AMC innovatively and cost effectively deals with missed appointments across hospitals and outpatient departments, leading to less cancellations and re-scheduling of appointments; resulting in an enhanced patient experience and significant reduction in associated costs.

 

The flexibility of the AMC suite will allow Trusts to expand the applications they use as the benefits of improved patient communication and appointment management are realised.

 

The judging panel of Building Better Healthcare Awards, 2012, headed by Roy Lilley, NHS Commentator, commented, "Appointment Management Cycle seems a simple solution, but it really makes a difference to the patient experience and to the number of missed appointments, saving the health service a lot of money."

 

Henrik Bang, CEO of Netcall, commented, "The growing number of implementations of Netcall's Appointment Management Cycle (AMC) is helping NHS Acute Trusts and Health Boards to significantly reduce their 'Did Not Attend' (DNA) rates, creating substantial costs savings for the organisations. The AMC solution set has been developed by focusing on our NHS customers' needs, and includes a variety of communication channels which enables Trusts and Health Boards to tailor communication to all age groups, including the younger generation who are considered the biggest offenders of missing appointments. We are delighted with the rapid success we have had in the uptake of our AMC solution set which Netcall continues to enhance, and we are currently in discussion with a number of NHS Acute Trusts about implementing AMC within their organisations."

 

 

For further enquiries, please contact:

 

Netcall plc

Tel. +44 (0) 330 333 6100

Henrik Bang, CEO

Michael Jackson, Chairman

James Ormondroyd, Group Finance Director

finnCap Limited (Nominated Adviser and Broker)

Tel. +44 (0) 20 7220 0500

Stuart Andrews, Corporate Finance

Victoria Bates / Simon Johnson, Corporate Broking

Newgate Threadneedle

Tel. +44 (0) 20 7653 9850

Caroline Evans-Jones / Hilary Millar/ Heather Armstrong

 

 

 

About Netcall plc

Netcall is a UK company quoted on the AIM market of the London Stock Exchange. Netcall's software product suite provides compelling business process solutions for end-to-end customer engagement, incorporating intelligent contact handling, workforce optimisation, business process management and enterprise content management. Our target markets comprise organisations of all sizes, including many blue-chip companies with global contact centre operations. The Netcall software platform helps organisations meet the growing demands of their customers and prospects whilst improving internal efficiencies, thereby increasing profitability and customer satisfaction.

 

Netcall's customer base contains nearly 750 organisations in both the private and public sectors. These include over 70%of the NHS Acute Health Trusts and Boards, major telecoms operators such as BT and Cable & Wireless and leading organisations including Interflora, Lloyds TSB, Cineworld, Interserve, Orange, Prudential and Thames Water.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUKUBROVASRAR
Date   Source Headline
27th May 20268:03 amRNSHolding(s) in Company
14th May 20263:07 pmRNSDirector/PDMR Shareholding
11th May 20263:10 pmRNSNotification of major holdings
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSIssue of Contingent Consideration Shares & TVR
17th Mar 20265:40 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSHalf-year Report
22nd Jan 20267:00 amRNSTrading Update and Notice of Results
7th Jan 20267:00 amRNS-R£3.0m Liberty Cloud Contract Win
17th Dec 20251:24 pmRNSResult of AGM
17th Dec 20257:00 amRNSAGM Statement
10th Dec 20257:00 amRNSAcquisition of Jadu Holdings Limited
20th Nov 20257:00 amRNSNotice of AGM and Posting of Annual Report
19th Nov 20257:00 amRNSIssue of Contingent Consideration Shares & TVR
29th Oct 20252:26 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSFinal Results for the Year Ended 30 June 2025
25th Sep 20252:49 pmRNSNotice of Results
22nd Aug 202511:48 amRNSHolding(s) in Company
4th Aug 20258:53 amRNSHolding(s) in Company
29th Jul 202512:41 pmRNSDirector/PDMR Shareholding
24th Jul 20253:34 pmRNSDirector/PDMR Shareholding
22nd Jul 20257:00 amRNSFY25 Trading Update
15th May 20257:00 amRNSExercise of Options and Total Voting Rights
15th Apr 20258:10 amRNSHolding(s) in Company
9th Apr 20253:52 pmRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSAIM Rule 17 – Notification of shareholding
19th Mar 202511:12 amRNSHolding(s) in Company
19th Mar 202510:04 amRNSDirector/PDMR Shareholding
13th Mar 20254:44 pmRNSExercise of Options and Total Voting Rights
10th Mar 20253:56 pmRNSHolding(s) in Company
5th Mar 20257:00 amRNSHalf-year Report
29th Jan 20255:51 pmRNSExercise of Options and Total Voting Rights
28th Jan 20255:41 pmRNSHolding(s) in Company
24th Jan 202511:58 amRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSTrading Update
9th Jan 20257:00 amRNSDirector/PDMR Shareholding
6th Jan 20253:27 pmRNSDirector/PDMR Shareholding
31st Dec 20247:00 amRNSEstablishment of New Long-Term Incentive Plan
18th Dec 20242:05 pmRNSHolding(s) in Company
18th Dec 202410:09 amRNSHolding(s) in Company
17th Dec 202411:44 amRNSResult of AGM
17th Dec 20247:00 amRNSAGM Statement
5th Dec 20243:54 pmRNSHolding(s) in Company
4th Dec 20244:04 pmRNSHolding(s) in Company
29th Nov 20245:21 pmRNSHolding(s) in Company
18th Nov 20247:00 amRNSNotice of AGM and Posting of Annual Report
15th Nov 202412:15 pmRNSHolding(s) in Company
7th Nov 20243:39 pmRNSExercise of Options and Total Voting Rights
25th Oct 20247:00 amRNSExercise of Options, Director/PDMR Dealing and TVR
14th Oct 20242:03 pmRNSDirector/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.